Provided by Tiger Trade Technology Pte. Ltd.

Splash Beverage Group Inc.

0.3526
+0.02256.82%
Post-market: 0.3400-0.0126-3.57%19:54 EDT
Volume:527.48K
Turnover:174.40K
Market Cap:2.22M
PE:-0.01
High:0.3544
Open:0.3213
Low:0.3100
Close:0.3301
52wk High:13.40
52wk Low:0.2500
Shares:6.30M
Float Shares:6.12M
Volume Ratio:0.54
T/O Rate:8.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-41.8800
EPS(LYR):-70.9984
ROE:-1130.20%
ROA:-533.21%
PB:-0.14
PE(LYR):0.00

Loading ...

Splash Beverage Extends Investor Settlement Payment Deadline, Sets July 31 Due Date for $137,797.54 at 12% Interest

Reuters
·
Jul 22

Splash Beverage Group - Amends Settlement Agreements with Three Prior Investors on July 15, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 22

Splash Beverage Group Sets 1-for-4 Reverse Stock Split Effective July 24

Reuters
·
Jul 14

Splash Beverage Group Announces Significant Balance Sheet Improvement and Board Approval of Reverse Stock Split as Company Continues Strategic Transformation

THOMSON REUTERS
·
Jul 14

Splash Beverage Group - Expects $2.75 Mln Gain from Extinguishment of Indebtedness

THOMSON REUTERS
·
Jul 14

Splash Beverage Group - Settles $3.3 Mln Liabilities for $550,000 Cash

THOMSON REUTERS
·
Jul 14

Splash Beverage Group to Repay Decathlon Alpha IV Loan for $301,800.55 Under Settlement Deal

Reuters
·
Jul 14

Splash Beverage Group Issues 9,232,047 Shares in Unregistered Sale, Raises $1.27 Million

Reuters
·
Jul 11

NYSE American Accepts Splash Beverage Compliance Plan, Sets Jan. 29, 2027 Deadline to Regain Listing Standards

Reuters
·
Jul 09

Splash Beverage Group Receives NYSE American Acceptance of Compliance Plan, Establishing Defined Path Toward Continued Listing and Strategic Transformation

THOMSON REUTERS
·
Jul 09

Top Premarket Decliners

MT Newswires Live
·
Jul 07

Argent Biopharma Ltd - to Receive a 15% Net Revenue Royalty on Future Sbev Global Cannepil Revenues

THOMSON REUTERS
·
Jul 07

Argent Biopharma - Enters a Global Licensing Transaction for Cannepil with Splash Beverage Group Inc

THOMSON REUTERS
·
Jul 07

Argent Biopharma - Transaction Includes $5.5 Mln Upfront Consideration for Global Licensing Rights

THOMSON REUTERS
·
Jul 07

Splash Beverage Group Secures Exclusive Worldwide License to Argent Biopharma’s Cannepil Epilepsy Drug

Reuters
·
Jul 07

Splash Beverage Acquires Exclusive Global Rights for Epilepsy Therapy CannEpil

MT Newswires Live
·
Jul 06

Mercer Street Fund Forgives USD 5 Million Argent Biopharma Debt in Cannepil Licensing Deal with Splash Beverage Group

Reuters
·
Jul 06

Splash Beverage Group - Argent Biopharma to Receive 15% Royalty on Worldwide Cannepil Sales

THOMSON REUTERS
·
Jul 06

Splash Beverage Group Acquires Exclusive Global Rights to Cannepil®, an Epilepsy Therapy with Established European Patient Access, FDA Engagement and U.S. Development Potential

THOMSON REUTERS
·
Jul 06

Splash Beverage Group - Buys Exclusive Worldwide Rights to Develop and Sell Cannepil

THOMSON REUTERS
·
Jul 06